Vivo Capital, LLC Io Biotech, Inc. Transaction History
Vivo Capital, LLC
- $683 Million
- Q3 2024
A detailed history of Vivo Capital, LLC transactions in Io Biotech, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 6,173,439 shares of IOBT stock, worth $5.62 Million. This represents 0.95% of its overall portfolio holdings.
Number of Shares
6,173,439
Previous 6,173,439
-0.0%
Holding current value
$5.62 Million
Previous $7.22 Million
10.25%
% of portfolio
0.95%
Previous 1.07%
Shares
2 transactions
Others Institutions Holding IOBT
# of Institutions
20Shares Held
23.6MCall Options Held
0Put Options Held
0-
Samsara Bio Capital, LLC Palo Alto, CA3.64MShares$3.31 Million2.22% of portfolio
-
Novo Holdings Hellerup, G73.35MShares$3.05 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$2.13 Million0.14% of portfolio
-
Morgan Stanley New York, NY2.2MShares$2 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$1.92 Million0.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $26.2M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...